Nasal cavity disorder
MONDO:0002232A disease involving the nasal cavity.
Also known as: disease of nasal cavity, disease or disorder of nasal cavity, disorder of nasal cavity, nasal cavity disease, nasal cavity disease or disorder, nasal cavity disorder
224 clinical trials for this condition and its sub-types, 3 tagged with Nasal cavity disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Nasal cavity disorder
-
Rhinitis 22 trials · 159 incl. sub-types
3 sub-types
- Allergic rhinitis 96 trials · 140 incl. sub-types Sub-types →
- Chronic rhinitis 14 trials
- Atrophic rhinitis 0 trials · 1 incl. sub-types Sub-types →
-
Nasal cavity polyp 39 trials
-
Nasal cavity neoplasm 1 trial · 15 incl. sub-types
3 sub-types
- Nasal cavity cancer 5 trials · 14 incl. sub-types Sub-types →
- Benign neoplasm of nasal cavity 1 trial Sub-types →
- Nasal cavity inverting papilloma 0 trials
-
Binder syndrome 7 trials
-
Choanal atresia 4 trials
2 sub-types
- Choanal atresia, bilateral 0 trials
- Choanal atresia, unilateral 0 trials
Most studied deeper sub-types
-
Can a steroid spray break the decongestant habit?
Disease control Stopped earlyThis small, early-stage trial tested a combination of a steroid spray (triamcinolone) and a decongestant spray (oxymetazoline) to help people who were dependent on decongestants stop using them. The study planned to slowly reduce the decongestant dose while keeping the steroid st…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Asthma drug tested for stubborn nasal polyps – trial cut short
Disease control Stopped earlyThis phase 3 study tested the drug benralizumab in 295 adults with severe nasal polyps and eosinophilic chronic sinusitis. Participants received injections of benralizumab or a placebo every 4 to 8 weeks for about a year. The goal was to see if the drug could shrink polyps and im…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Hay fever education trial fizzles out: did extra lessons help?
Symptom relief Stopped earlyThis study tested whether teaching teens and young adults (ages 14-29) the correct way to use nasal sprays for hay fever would improve their symptoms compared to standard care. The trial was terminated early and enrolled only 18 participants. The goal was to see if repeat educati…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple nasal device boost mood and ease congestion?
Symptom relief Stopped earlyThis study tested whether using the SinuSonic device—a handheld tool that uses sound and gentle pressure to relieve nasal congestion—could also improve anxiety, depression, and overall well-being in adults with chronic stuffy nose. Sixteen participants used the device for 5 weeks…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Preterm Kids' lungs under the microscope: study halted early
Knowledge-focused Stopped earlyThis study aimed to track lung function in children born prematurely (before 37 weeks) aged 3 to 5 years, comparing them to full-term children. Researchers used breathing tests and samples to look for early signs of asthma and allergies. The study was terminated early, so results…
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC